Vector-based miR-15a/16-1 plasmid inhibits colon cancer growth in vivo

Cell Biology International

Volumn 36, Issue 8, 2012, Pages 765-770

  Dai, Lixia ^a   Wang, Wei ^a   Zhang, Shuang ^a   Jiang, Qingyuan ^b   Wang, Ruibo ^a   Dai, Lei ^a   Cheng, Lin ^a   Yang, Yang ^a   Wei, Yu Quan ^a   Deng, Hong Xin ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Anti angiogenesis; Cancer therapy; CCNB1; miR 15a 16 1

Indexed keywords

ANTINEOPLASTIC AGENT; CD31 ANTIGEN; CYCLIN B1; CYCLINE; MESSENGER RNA; MICRORNA; MICRORNA 15A 16 1; PLASMID VECTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN HCT116; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; IN VIVO STUDY; LIPOSOMAL GENE DELIVERY SYSTEM; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; TUMOR XENOGRAFT; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; ANIMALS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLIN B1; DOWN-REGULATION; FEMALE; GENETIC VECTORS; HCT116 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; MICE, NUDE; MICRORNAS; PLASMIDS; RNA INTERFERENCE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84865085480     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20110404     Document Type: Article

References (32)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
2. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L et al. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 2008;14:1271-77.
3. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M et al. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci USA 2008;105:5166-71.
4. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. Frequent deletions and down-regulation of microRNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002;99:15524-29.
5. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-57.
6. Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 2005;33:1290-97.
7. Chen L, Yan HX, Yang W, Hu L, Yu LX, Liu Q et al. The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. J Hepatol 2009;50:358-69.
8. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005;102:13944-49.
9. Cristofanilli M, Charnsangavej C, Hortobagyi GN. Angiogenesis modulation in cancer research: novel clinical approaches. Nat Rev Drug Discov 2002;1:415-26.
10. Croce MC. Oncogenes and Cancer. N Engl J Med 2008;358:502-11.
11. Di Leva G, Croce CM. Roles of small RNAs in tumor formation. Trends Mol Med 2010;16:257-67.
12. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006;6:259-69.
13. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:765-81.
14. Fish JE, Srivastava D. MicroRNAs: opening a new vein in angiogenesis research. Sci Signal 2008;2:pe1.
15. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-86.
16. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-56.
17. Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics 2010. CA Cancer J Clin 2010;60:277-300.
18. Kim VN, Nam JW. Genomics of microRNA. Trends Genet 2006;22:165-73.
19. Klein U, Lia M, Crespo M, Siegel R, Shen Q, Mo T et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 2010;17:28-40.
20. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006;11:441-50.
21. Kuehbacher A, Urbich C, Dimmeler S. Targeting microRNA expression to regulate angiogenesis. Trends Pharmacol Sci 2008;29:12-15.
22. Lerner M, Harada M, Lovén J, Castro J, Davis Z, Oscier D et al. DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1. Exp Cell Res 2009;315:2941-52.
23. Lu C, Stewart DJ, Ji L, Ramesh R, Jayachandran G et al. A phase I trial of intravenous therapy with tumor suppressor FUS1-nanoparticles. J Clin Oncol 2009;27:e19065.
24. Pai SI, Lin YY, Macaes B, Meneshian A, Hung CF, Wu TC. Prospects of RNA interference therapy for cancer. Gene Ther 2006;13:464-77.
25. Pang X, Yi T, Yi Z, Cho SG, Qu W, Pinkaew D et al. Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways. Cancer Res 2009;69:518-25.
26. Qian DZ, Wang XF, Kachhap SK, Kato Y, Wei Y, Zhang L et al. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584. Cancer Res 2004;64:6626-34.
27. Ruan K, Fang X, Ouyang G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett 2009;285:116-26.
28. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 2008;3:1101-08.
29. Templeton NS, Lasic DD, Frederik PM, Strey HH, Roberts DD, Pavlakis GN. Improved DNA:liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol 1997;15:647-52.
30. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008;15:261-71.
31. Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007;302:1-12.
32. Zhang X, Deng HX, Zhao X, Su D, Chen XC, Chen LJ et al. RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitro and in vivo. Oncology 2009; 77: 22-32.